Clinical Cough VI: The Need for New Therapies for Cough: Disease-Specific and Symptom-Related Antitussives

  • K. F. Chung
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 187)


Cough is a common symptom that can be self-limiting or persistent. Ideally, treatment of the underlying cause(s) of cough with specific treatments should eliminate cough. This approach may not be successful if no cause can be established or if the treatment of the cause fails. Suppression of cough may be disease-specific or symptom-related. There has been a long tradition in acute cough usually due to upper respiratory tract infections to use symptom-related antitussives. In chronic cough, suppression of cough may be achieved by disease-specific therapies, but in many patients it may be necessary to use symptomatic antitussives. The efficacy of some over-the-counter symptomatic antitussives is often no better than that of a placebo. Currently available cough suppressants include the centrally acting opioids such as morphine, codeine, pholcodeine, and dextromethorphan. Early studies reported success in reducing cough in patients with chronic bronchitis or chronic obstructive pulmonary disease (COPD); however, a carefully conducted blinded controlled study showed no effect of codeine on cough of COPD. Success with these cough suppressants may be achieved at high doses that are associated with side effects. A slow-release preparation of morphine has been shown to have some degree of efficacy, but this should be reserved for the most severe chronic cough patient, and for patients with terminal cancer who may also benefit from its analgesic effects. There are case reports of the success of centrally acting drugs such as amitriptyline, paroxetine, gabapentin, and carbamezepine in chronic cough. New agents derived from basic research such as new opioids such as nociceptin or antagonists of transient receptor potential vanniloid-1 may turn out to have antitussive effects. Efficacy of symptomatic cough suppressants must be tested in double-blind randomized trials using validated measures of cough in patients with chronic cough not responding to specific treatments. Patients with chronic cough need effective antitussives that could be used either on demand or on a long-term basis.


Chronic Cough Acute Cough TRPV1 Antagonist Cough Suppressant Antitussive Effect 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adams R, Hosie J, James I, Khong T, Smith I et al (1993) Antitussive activity and tolerability of moguisteine in patients with acute cough: a randomized, double-blind, placebo-controlled study. Adv Ther 10:263–271Google Scholar
  2. Adcock JJ, Schneider C, Smith TW (1988) Effects of codeine, morphine and a novel opioid pen-tapeptide BW443C, on cough, nociception and ventilation in the unanaesthetized guinea-pig. Br J Pharmacol 93:93–100PubMedGoogle Scholar
  3. Adcock JJ, Douglas GJ, Garabette M, Gascoigne M, Beatch G, Walker M, Page CP (2003) RSD931, a novel anti-tussive agent acting on airway sensory nerves. Br J Pharmacol 138: 407–416PubMedGoogle Scholar
  4. Advenier C, Giraud V, Naline E, Villain P, Emonds-Alt X (1992) Antitussive effect of SR 48968, a non-peptide tachykinin NK2 receptor antagonist. Eur J Pharmacol 250:169–173Google Scholar
  5. Allegra L, Bossi R (1988) Clinical trials with the new antitussive levodropropizine in adult bronchitic patients. Arzneimittelforschung 38:1163–1166PubMedGoogle Scholar
  6. Aversa C, Cazzola M, Clini , Dal Negro R, Maiorano V, Tana F, Allegra L (1993) Clinical trial of the efficacy and safety of moguisteine in patients with cough associated with chronic respiratory diseases. Drugs Exp Clin Res 19:273–279PubMedGoogle Scholar
  7. Aylward M, Maddock J, Dewland P (1980) Clinical evaluation of acetylcysteine in the treatment of patients with chronic obstructive bronchitis: a balanced double-blind trial with placebo control. Eur J Respir Dis Suppl 111:81–89Google Scholar
  8. Aylward M, Maddock J, Davies DE, Protheroe DA, Leideman T (1984) Dextromethorphan and codeine: comparison of plasma kinetics and antitussive effects. Eur J Respir Dis 65:283–291PubMedGoogle Scholar
  9. Barbee RA, Halonen M, Kaltenborn WT, Burrows B (1991) A longitudinal study of respiratory symptoms in a community population sample. Correlations with smoking, allergen skin-test reactivity, and serum IgE. Chest 99:20–26PubMedGoogle Scholar
  10. Bastian RW, Vaidya AM, Delsupehe KG (2006) Sensory neuropathic cough: a common and treatable cause of chronic cough. Otolaryngol Head Neck Surg 135:17–21PubMedGoogle Scholar
  11. Bergren DR (1997) Sensory receptor activation by mediators of defense reflexes in guinea-pig lungs. Respir Physiol 108:195–204PubMedGoogle Scholar
  12. Bock MG, Longmore J (2000) Bradykinin antagonists: new opportunities. Curr Opin Chem Biol 4:401–406PubMedGoogle Scholar
  13. Bolser DC (2006a) Cough suppressant and pharmacologic protussive therapy: ACCP evidence-based clinical practice guidelines. Chest 129:238S–249SGoogle Scholar
  14. Bolser DC (2006b) Current and future centrally acting antitussives. Respir Physiol Neurobiol 152:349–355Google Scholar
  15. Bolser DC, Degennaro FC, O'Reilly S, Chapman RW, Kreutner W, Egan RW, Hey JA (1994) Peripheral and central sites of action of GABA-B agonists to inhibit the cough reflex in the cat and guinea pig. Br J Pharmacol 113:1344–1348PubMedGoogle Scholar
  16. Bolser DC, McLeod RL, Tulshian DB, Hey JA (2001) Antitussive action of nociceptin in the cat. Eur J Pharmacol 430:107–111PubMedGoogle Scholar
  17. Braun-Fahrlander C, Vuille JC, Sennhauser FH, Neu U, Kunzle T, Grize L, Gassner M, Minder C, Schindler C, Varonier HS, Wuthrich B (1997) Respiratory health and long-term exposure to air pollutants in Swiss schoolchildren. SCARPOL Team. Swiss Study on Childhood Allergy and Respiratory Symptoms with Respect to Air Pollution, Climate and Pollen. Am J Respir Crit Care Med 155:1042–1049PubMedGoogle Scholar
  18. Brightling CE, Ward R, Wardlaw AJ, Pavord ID (2000) Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis. Eur Respir J 15:682–686PubMedGoogle Scholar
  19. Calignano A, Katona I, Desarnaud F, Giuffrida A, La Rana G, Mackie K, Freund TF, Piomelli D (2000) Bidirectional control of airway responsiveness by endogenous cannabinoids. Nature 408:96–101PubMedGoogle Scholar
  20. Carr MJ (2006) Influence of mexiletine on action potential discharge and conduction in nodose Adelta afferent neurons innervating guinea pig isolated trachea. Pulm Pharmacol Ther 19: 258–263PubMedGoogle Scholar
  21. Catena E, Daffonchio L (1997) Efficacy and tolerability of levodropropizine in adult patients with non-productive cough. Comparison with dextromethorphan. Pulm Pharmacol Ther 10:89–96PubMedGoogle Scholar
  22. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D (1997) The capsaicin receptor: A heat-activated ion channel in the pain pathway. Nature 389:816–824PubMedGoogle Scholar
  23. Chang AB, Halstead RA, Petsky HL (2005) Methylxanthines for prolonged non-specific cough in children. Cochrane. Database Syst Rev CD005310Google Scholar
  24. Chang AB, Lasserson TJ, Kiljander TO, Connor FL, Gaffney JT, Garske LA (2006) Systematic review and meta-analysis of randomised controlled trials of gastro-oesophageal reflux interventions for chronic cough associated with gastro-oesophageal reflux. Br Med J 332:11–17Google Scholar
  25. Chapman RW, Hey JA, Rizzo CA, Bolser DC (1993) GABAB receptors in the lung. Trends Pharmacol Sci 14:26–29PubMedGoogle Scholar
  26. Chiou LC, Liao YY, Fan PC, Kuo PH, Wang CH, Riemer C, Prinssen EP (2007) Noci-ceptin/orphanin FQ peptide receptors: pharmacology and clinical implications. Curr Drug Targets 8:117–135PubMedGoogle Scholar
  27. Chong CF, Chen CC, Ma HP, Wu YC, Chen YC, Wang TL (2005) Comparison of lidocaine and bronchodilator inhalation treatments for cough suppression in patients with chronic obstructive pulmonary disease. Emerg Med J 22:429–432PubMedGoogle Scholar
  28. Choudry NB, Fuller RW, Anderson N, Karlsso JA (1990) Separation of cough and reflex bronchoconstriction by inhaled local anaesthetics. Eur Respir J 3:579–583PubMedGoogle Scholar
  29. Choudry NB, Gray SJ, Posner J, Fuller RW (1991) The effect of 443C81, a mu opioid receptor agonist, on the response to inhaled capsaicin in healthy volunteers. Br J Clin Pharmacol 32:633–636PubMedGoogle Scholar
  30. Chung KF (2005) Drugs to suppress cough. Expert Opin Investig Drugs 14:19–27PubMedGoogle Scholar
  31. Chung KF (2006) Measurement of cough. Respir Physiol Neurobiol 152:329–339PubMedGoogle Scholar
  32. Chung KF (2007) Effective antitussives for the cough patient: An unmet need. Pulm.Pharmacol Ther 20:438–445PubMedGoogle Scholar
  33. Chung KF, Pavord ID (2008) Prevalence, pathogenesis and causes of chronic cough. Lancet 371:1364–74PubMedGoogle Scholar
  34. Chung KF, Hew M, Score J, Jones AV, Reiter A, Cross NC, Bain BJ (2006) Cough and hypereosinophilia due to FIP1L1-PDGFRA fusion gene with tyrosine kinase activity. Eur Respir J 27:230–232PubMedGoogle Scholar
  35. Clemens CJ, Taylor JA, Almquist JR, Quinn HC, Mehta A, Naylor GS (1997) Is an antihistamine-decongestant combination effective in temporarily relieving symptoms of the common cold in preschool children? J Pediatr 130:463–466PubMedGoogle Scholar
  36. Coleridge HM, Coleridge JCG (1986) Reflexes evoked from the respiratory tract and lungs. In: Cherniack NS, Widdicombe JG (eds) Handbook of physiology section 3: The Respiratory System, vol II, Control of Breathing Part 1. American Physiological Society, Bethesda, pp 395–429Google Scholar
  37. Committee on Drugs (1997) Use of codeine- and dextromethorphan-containing cough remedies in children. Pediatrics 99:918–920Google Scholar
  38. Cook DG, Strachan DP (1999) Health effects of passive smoking-10: Summary of effects of arental smoking on the respiratory health of children and implications for research. Thorax54:357–366PubMedGoogle Scholar
  39. Corboz MR, Rivelli MA, Egan RW, Tulshian D, Matasi J, Fawzi AB, Benbow L, Smith-Torhan A, Zhang H, Hey JA (2000) Nociceptin inhibits capsaicin-induced bronchoconstriction in isolated guinea pig lung. Eur J Pharmacol 402:171–179PubMedGoogle Scholar
  40. Coyle MA, Keenan DB, Henderson LS, Watkins ML, Haumann BK, Mayleben DW, Wilson MG (2005) Evaluation of an ambulatory system for the quantification of cough frequency in patients with chronic obstructive pulmonary disease. Cough 1:3PubMedGoogle Scholar
  41. Cullinan P (1992) Persistent cough and sputum: prevalence and clinical characteristics in south east England. Respir Med 86:143–149PubMedGoogle Scholar
  42. Daoui S, Cognon C, Naline E, Emonds-Alt X, Advenier C (1998) Involvement of tachykinin NK3 receptors in citric acid-induced cough and bronchial responses in guinea pigs. Am J Respir Crit Care Med 158:42–48PubMedGoogle Scholar
  43. Dicpinigaitis PV (2006) Current and future peripherally-acting antitussives. Respir Physiol Neu-robiol 152:356–362Google Scholar
  44. Dicpinigaitis PV, Dobkin JB (1997) Antitussive effect of the GABA-agonist baclofen. Chest 111:996–999PubMedGoogle Scholar
  45. Dicpinigaitis PV, Dobkin JB (1999) Effect of zafirlukast on cough reflex sensitivity in asthmatics. J Asthma 36:265–270PubMedGoogle Scholar
  46. Dicpinigaitis PV, Rauf K (1998) Treatment of chronic, refractory cough with baclofen. Respiration 65:86–88PubMedGoogle Scholar
  47. Dicpinigaitis PV, Dobkin JB, Rauf K, Aldrich TK (1998) Inhibition of capsaicin-induced cough by the gamma-aminobutyric acid agonist baclofen. J Clin Pharmacol 38:364–367PubMedGoogle Scholar
  48. Doherty MJ, Mister R, Pearson MG, Calverley PM (2000) Capsaicin responsiveness and cough in asthma and chronic obstructive pulmonary disease. Thorax 55:643–649PubMedGoogle Scholar
  49. Eccles R (2002) The powerful placebo in cough studies? Pulm Pharmacol Ther 15:303–308PubMedGoogle Scholar
  50. Eccles R, Morris S, Jawad M (1992) Lack of effect of codeine in the treatment of cough associated with acute upper respiratory tract infection. J Clin Pharm Ther 17:175–180PubMedGoogle Scholar
  51. Eddy NB, Friebel H, Hahn KJ, Halbach H (1969a) Codeine and its alternates for pain and cough relief. 4. Potential alternates for cough relief. Bull World Health Organ 40:639–719Google Scholar
  52. Eddy NB, Friebel H, Hahn KJ, Halbach H (1969b) Codeine and its alternates for pain and cough relief. 3. The antitussive action of codeine-mechanism, methodology and evaluation. Bull World Health Organ 40:425–454Google Scholar
  53. Empey DW, Laitinen LA, Young GA, Bye CE, Hughes DT (1979) Comparison of the antitussive effects of codeine phosphate 20 mg, dextromethorphan 30 mg and noscapine 30 mg using citric acid-induced cough in normal subjects. Eur J Clin Pharmacol 16:393–397PubMedGoogle Scholar
  54. Fahy JV, Wong HH, Geppetti P, Reis JM, Harris SC, Maclean DB, Nadel JA, Boushey HA (1995) Effect of an NK1 antagonist (CP-99,994) on hypertonis saline- induced bronchoconstriction and cough in male asthmatic subjects. Am J Resp Crit Care Med 152:879–884PubMedGoogle Scholar
  55. Featherstone RL, Parry JE, Evans DM, Jones DM, Olsson H, Szelke M, Church MK (1996) Mechanism of irritant-induced cough: studies with a kinin antagonist and a kallikrein inhibitor. Lung 174:269–275PubMedGoogle Scholar
  56. Fischer A, Forssmann WG, Undem BJ (1998) Nociceptin-induced inhibition of tachykinergic neu-rotransmission in guinea pig bronchus. J Pharmacol Exp Ther 285:902–907PubMedGoogle Scholar
  57. Ford AC, Forman D, Moayyedi P, Morice AH (2006) Cough in the community: A cross sectional survey and the relationship to gastrointestinal symptoms. Thorax 61:975–979PubMedGoogle Scholar
  58. Ford CN (2005) Evaluation and management of laryngopharyngeal reflux. J Am Med Assoc 294:1534–1540Google Scholar
  59. Fox AJ, Urban L, Barnes PJ, Dray A (1995) Effects of casazepine against capsaicin- and proton-evoked excitation of single airway c-fibres and vagus nerve from the guinea-pig. Neurosci Lett 15:421–428Google Scholar
  60. Fox AJ, Barnes PJ, Venkatesan P, Belvisi MG (1997) Activation of large conductance potassium channels inhibits the afferent and efferent function of airway sensory nerves in the guinea pig. J Clin Invest 99:513–519PubMedGoogle Scholar
  61. Freestone C, Eccles R (1997) Assessment of the antitussive efficacy of codeine in cough associated with common cold. J Pharm Pharmacol 49:1045–1049PubMedGoogle Scholar
  62. Fujimura M, Kamio Y, Myou S, Hashimoto T (2000) Effect of oral mexiletine on the cough response to capsaicin and tartaric acid. Thorax 55:126–128PubMedGoogle Scholar
  63. Garcia-Martinez C, Humet M, Planells-Cases R,Gomis A,Caprini M, Viana F,DeLa PE, Sanchez-Baeza F, Carbonell T, De Felipe C, Perez-Paya E, Belmonte C, Messeguer A, Ferrer-Montiel A (2002) Attenuation of thermal nociception and hyperalgesia by VR1 blockers. Proc Natl Acad Sci USA 99:2374–2379PubMedGoogle Scholar
  64. Gehring U, Cyrys J, Sedlmeir G, Brunekreef B, Bellander T, Fischer P, Bauer CP, Reinhardt D, Wichmann HE, Heinrich J (2002) Traffic-related air pollution and respiratory health during the first 2 yrs of life. Eur Respir J 19:690–698PubMedGoogle Scholar
  65. Geppetti P, Tognetto M, Trevisani M, Amadesi S, Bertrand C (1999) Tachykinins and kinins in airway allergy. Expert Opin Investig Drugs 8:947–956PubMedGoogle Scholar
  66. Girard V, Naline E, Vilain P, Emonds-Alt X, Advenier C (1995) Effect of the two tachykinin antagonists, SR 48968 and SR 140333, on cough induced by citric acid in the unanaesthetized guinea pig. Eur Respir J 8:1110–1114PubMedGoogle Scholar
  67. Gordon R, Gordon RJ, Sofia D (1976) Antitussive activity of some naturally occurring cannabinoids in anesthetized cats. Eur J Pharmacol 35:309–313PubMedGoogle Scholar
  68. Gracely RH, Undem BJ, Banzett RB (2007) Cough, pain and dyspnoea: Similarities and differences. Pulm Pharmacol Ther 20:433–437PubMedGoogle Scholar
  69. Groneberg DA, Niimi A, Dinh QT, Cosio B, Hew M, Fischer A, Chung KF (2004) Increased expression of transient receptor potential Vanilloid-1 in airway nerves of chronic cough. Am J Respir Crit Care Med 170(12):1276–1280PubMedGoogle Scholar
  70. Hansson L, Midgren B, Karlsson JA (1994) Effects of inhaled lignocaine and adrenaline on capsaicin-induced cough in humans. Thorax 49:1166–1168PubMedGoogle Scholar
  71. Hautmeyers E, Gosselink R, Gayan-Ramirez G, Decramer M (1999) Effects of drugs on mucus clearance. Eur Respir J 14:452–467Google Scholar
  72. Hay DW, Giardina GA, Griswold DE, Underwood DC, Kotzer CJ, Bush B, Potts W, Sandhu P, Lundberg D, Foley JJ, Schmidt DB, Martin LD, Kilian D, Legos JJ, Barone FC, Luttmann MA, Grugni M, Raveglia LF, Sarau HM (2002) Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea pigs. J Pharmacol Exp Ther 300:314–323PubMedGoogle Scholar
  73. Heino M, Juntunen-Backman K, Leijala M, Rapola J, Laitinen LA (1990) Bronchial epithelial inflammation in children with chronic cough after early lower respiratory tract illness. Am Rev Respir Dis 141:428–432PubMedGoogle Scholar
  74. Howard P, Cayton RM, Brennan SR, Anderson PB (1977) Lignocaine aerosol and persistent cough. Br J Dis Chest 71:19–24PubMedGoogle Scholar
  75. Hutton N, Wilson MH, Mellits ED, Baumgardner R, Wissow LS, Bonuccelli C, Holtzman NA, DeAngelis C (1991) Effectiveness of an antihistamine-decongestant combination for young children with the common cold: a randomized, controlled clinical trial. J Pediatr 118:125–130PubMedGoogle Scholar
  76. Irwin RS (2006) Introduction to the diagnosis and management of cough: ACCP evidence-based clinical practice guidelines. Chest 129:25S–27SPubMedGoogle Scholar
  77. Irwin RS, Carrao WM, Pratter MR (1981) Chronic persistent cough in the adult: The spectrum and frequency of causes and successful outcome of specific therapy. Am Rev Respir Dis 123:413–417PubMedGoogle Scholar
  78. Jacome DE (1985) La toux diabolique: neurogenic tussive crisis. Postgrad Med J 61:515–516PubMedGoogle Scholar
  79. Janson C, Chinn S, Jarvis D, Burney P (2001) Determinants of cough in young adults participating in the European community respiratory health survey. Eur Respir J 18:647–654PubMedGoogle Scholar
  80. Jeyakumar A, Brickman TM, Haben M (2006) Effectiveness of amitriptyline versus cough suppressants in the treatment of chronic cough resulting from postviral vagal neuropathy. Laryngoscope 116:2108–2112PubMedGoogle Scholar
  81. Jia Y, Wang X, Aponte SI, Rivelli MA, Yang R, Rizzo CA, Corboz MR, Priestley T, Hey JA (2002) Nociceptin/orphanin FQ inhibits capsaicin-induced guinea-pig airway contraction through an inward-rectifier potassium channel. Br J Pharmacol 135:764–770PubMedGoogle Scholar
  82. Kamei J, Tanihara H, Kasuya Y (1990) Antitussive effects of two specific k-opioid agonists, U-50, 448H and U-62, 066E, in rats. Eur J Pharmacol 199:281–286Google Scholar
  83. Kohno S, Ishida T, Uchida Y, Kishimoto H, Sasaki H, Shioya T, Tokuyama K, Niimi A, Nishi K, Fujimura M, Matsuse H, Suzaki H (2006) The Japanese respiratory society guidelines for management of cough. Respirology 11(Suppl 4):S135–S186PubMedGoogle Scholar
  84. Kollarik M, Undem BJ (2006) Sensory transduction in cough-associated nerves. Respir Physiol Neurobiol 152:243–254PubMedGoogle Scholar
  85. Korppi M, Laurikainen K, Pietikainen M, Silvasti M (1991) Antitussives in the treatment of acute transient cough in children. Acta Paediatr Scand 80:969–971PubMedGoogle Scholar
  86. Kotzer CJ, Hay DW, Dondio G, Giardina G, Petrillo P, Underwood DC (2000) The antitussive activity of delta-opioid receptor stimulation in guinea pigs. J Pharmacol Exp Ther 292: 803–809PubMedGoogle Scholar
  87. Kwong K, Lee LY (2005) Prostaglandin E2 potentiates a TTX-resistant sodium current in rat capsaicin-sensitive vagal pulmonary sensory neurones. J Physiol 564:437–450PubMedGoogle Scholar
  88. Lalloo UG, Fox AJ, Belvisi MG, Chung KF, Barnes PJ (1995) Inhibition by capsazepine of cough induced by capsaicin and citric acid, but not by hypertonic saline in awake guinea-pigs. J Appl Physiol 79:1082–1087PubMedGoogle Scholar
  89. Lavezzo A, Melillo G, Clavenna G, Omini C (1992) Peripheral site of action of levodropropizine in experimentally-induced cough: role of sensory neuropeptides. Pulm Pharmacol 5:143–147PubMedGoogle Scholar
  90. Lee MG, MacGlashan DW Jr, Undem BJ (2005) Role of chloride channels in bradykinin-induced guinea pig airway vagal C-fibre activation. J Physiol 566:205–212PubMedGoogle Scholar
  91. Lee MG, Undem BJ, Brown C, Carr MJ (2006) Effect of nociceptin in acid-evoked cough and airway sensory nerve activation in guinea pigs. Am J Respir Crit Care Med 173:271–275PubMedGoogle Scholar
  92. Lee PCL, Jawad MS, Eccles R (2000) Antitussive efficacy of dextromethorphan in cough associated with acute upper respiratory tract infection. J Pharm Pharmacol 52:1137–1142PubMedGoogle Scholar
  93. Leung SY, Niimi A, Williams AS, Nath P, Blanc FX, Din QT, Chung KF (2007) Inhibition of citric acid- and capsaicin-induced cough by novel TRPV-1 antagonist, V112220, in guinea-pig. Cough 3:10PubMedGoogle Scholar
  94. Lundback B, Nystrom L, Rosenhall L, Stjernberg N (1991) Obstructive lung disease in northern Sweden: respiratory symptoms assessed in a postal survey. Eur Respir J 4:257–266PubMedGoogle Scholar
  95. Matthys H, Bleicher B, Bleicher U (1983) Dextromethorphan and codeine: objective assessment of antitussive activity in patients with chronic cough. J Int Med Res 11:92–100PubMedGoogle Scholar
  96. Mazzone SB (2004) Sensory regulation of the cough reflex. Pulm Pharmacol Ther 17:361–368PubMedGoogle Scholar
  97. Mazzone SB, McGovern AE (2006). Na + -K + -2Cl- cotransporters and Cl- channels regulate citric acid cough in guinea pigs. J Appl Physiol 101:635–643PubMedGoogle Scholar
  98. Mazzone SB, Mori N, Canning BJ (2005) Synergistic interactions between airway afferent nerve subtypes regulating the cough reflex in guinea pigs. J Physiol 569:559–573PubMedGoogle Scholar
  99. Mazzone SB, McLennan L, McGovern AE, Egan GF, Farrell MJ (2007) Representation of capsaicin-evoked urge-to-cough in the human brain using functional magnetic resonance imaging. Am J Respir Crit Care Med 176:327–332PubMedGoogle Scholar
  100. McLeod RL, Parra LE, Mutter JC, Erickson CH, Carey GJ, Tulshian DB, Fawzi AB, Smith-Torhan A, Egan RW, Cuss FM, Hey JA (2001) Nociceptin inhibits cough in the guinea-pig by activation of ORL(1) receptors. Br J Pharmacol 132:1175–1178PubMedGoogle Scholar
  101. McLeod RL, Jia Y, Fernandez X, Parra LE, Wang X, Tulshian DB, Kiselgof EJ, Tan Z, Fawzi AB, Smith-Torhan A, Zhang H, Hey JA (2004) Antitussive profile of the NOP agonist Ro-64–6198 in the guinea pig. Pharmacology 71:143–149PubMedGoogle Scholar
  102. McLeod RL, Fernandez X, Correll CC, Phelps TP, Jia Y, Wang X, Hey JA (2006) TRPV1 antagonists attenuate antigen-provoked cough in ovalbumin sensitized guinea pigs. Cough 2:10PubMedGoogle Scholar
  103. McLeod RL, Correll CC, Jia Y, Anthes JC (2007a) TRPV1 antagonists as potential antitussive agents. Lung 186(Suppl 1):S59–65Google Scholar
  104. McLeod RL, Jia Y, McHugh NA, Fernandez X, Mingo GG, Wang X, Parra LE, Chen J, Brown D, Bolser DC, Kreutner W, Hey JA (2007b) Sulfur-dioxide exposure increases TRPV1-mediated responses in nodose ganglia cells and augments cough in guinea pigs. Pulm.Pharmacol Ther 20:750–757Google Scholar
  105. Mintz S, Lee JK (2006) Gabapentin in the treatment of intractable idiopathic chronic cough: case reports. Am J Med 119:e13–e15PubMedGoogle Scholar
  106. Morice AH, Marshall AE, Higgins KS, Grattan TJ (1994) Effect of inhaled menthol on citric acid induced cough in normal subjects. Thorax 49:1024–1026PubMedGoogle Scholar
  107. Morice AH, Fontana GA, Sovijarvi AR, Pistolesi M, Chung KF, Widdicombe JG, O'Connell F, Geppetti P, Gronke L, De Jongste J, Belvisi M, Dicpinigaitis P, Fischer A, McGarvey L, Fokkens WJ, Kastelik J (2004) The diagnosis and management of chronic cough. Eur Respir J 24: 481–492PubMedGoogle Scholar
  108. Morice AH, McGarvey L, Pavord I (2006) Recommendations for the management of cough in adults. Thorax 61(Suppl 1):i1–i24PubMedGoogle Scholar
  109. Morice AH, Menon MS, Mulrennan SA, Everett CF, Wright C, Jackson J, Thompson R (2007) Opiate therapy in chronic cough. Am J Respir Crit Care Med 175:312–315PubMedGoogle Scholar
  110. Morice AH, McGarvey L (2008) Clinical cough 1: Therapeutic treatments and management of chronic cough. In: Chung KF, Widdicombe JG (eds) Handbook of pharmacology. Pharmacology and therapeutics of cough. Springer, Berlin, this issueGoogle Scholar
  111. Morita K, Kamei J (2000) Involvement of ATP-sensitive K(+) channels in the anti-tussive effect of moguisteine. Eur J Pharmacol 395:161–164PubMedGoogle Scholar
  112. Morita K, Kamei J (2003) Antitussive effect of WIN 55212–2, a cannabinoid receptor agonist. Eur J Pharmacol 474:269–272PubMedGoogle Scholar
  113. Mund E, Christensson B, Larsson K, Gronneberg R (2001) Sex dependent differences in physiological ageing in the immune system of lower airways in healthy non-smoking volunteers: study of lymphocyte subsets in bronchoalveolar lavage fluid and blood. Thorax 56:450–455PubMedGoogle Scholar
  114. Mund E, Christensson B, Gronneberg R, Larsson K (2005) Noneosinophilic CD4 lymphocytic airway inflammation in menopausal women with chronic dry cough. Chest 127:1714–1721PubMedGoogle Scholar
  115. Mutoh T, Bonham AC, Joad JP (2000) Substance P in the nucleus of the solitary tract augments bronchopulmonary C fiber reflex output. Am J Physiol Regul Integr Comp Physiol 279:R1215– R1223PubMedGoogle Scholar
  116. Niimi A, Torrego A, Nicholson AG, Cosio BG, Oates TB, Chung KF (2005) Nature of airway inflammation and remodeling in chronic cough. J Allergy Clin Immunol 116:565–570PubMedGoogle Scholar
  117. Novitsky YW, Zawacki JK, Irwin RS, French CT, Hussey VM, Callery MP (2002) Chronic cough due to gastroesophageal reflux disease: efficacy of antireflux surgery. Surg Endosc 16:567–571PubMedGoogle Scholar
  118. O'Hara J, Jones NS (2005) The aetiology of chronic cough: a review of current theories for the otorhinolaryngologist. J Laryngol Otol 119:507–514PubMedGoogle Scholar
  119. Parvez L, Vaidya M, Sakhardande A, Subburaj S, Rajagopalan TG (1996) Evaluation of antitussive agents in man. Pulm Pharmacol 9:299–308PubMedGoogle Scholar
  120. Patel HJ, Birrell MA, Crispino N, Hele DJ, Venkatesan P, Barnes PJ, Yacoub MH, Belvisi MG (2003) Inhibition of guinea-pig and human sensory nerve activity and the cough reflex in guinea-pigs by cannabinoid (CB2) receptor activation. Br J Pharmacol 140:261–268PubMedGoogle Scholar
  121. Paul IM, Yoder KE, Crowell KR, Shaffer ML, McMillan HS, Carlson LC, Dilworth DA, Berlin CM Jr (2004) Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics 114:e85–e90PubMedGoogle Scholar
  122. Paul IM, Beiler J, McMonagle A, Shaffer ML, Duda L, Berlin CM Jr (2007) Effect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents. Arch Pediatr Adolesc Med 161:1140–1146PubMedGoogle Scholar
  123. Pavesi L, Subburaj S, Porter-Shaw K (2001) Application and validation of a computerized cough acquisition system for objective monitoring of acute cough: a meta-analysis. Chest 120:1121–1128PubMedGoogle Scholar
  124. Pavord IM, Chung KF (2008) Chronic cough: treatment and management. LancetGoogle Scholar
  125. Pierse N, Rushton L, Harris RS, Kuehni CE, Silverman M, Grigg J (2006) Locally generated particulate pollution and respiratory symptoms in young children. Thorax 61:216–220PubMedGoogle Scholar
  126. Premkumar LS, Ahern GP (2000) Induction of vanilloid receptor channel activity by protein kinase C. Nature 408:985–990PubMedGoogle Scholar
  127. Rouget C, Cui YY, D'Agostino B, Faisy C, Naline E, Bardou M, Advenier C (2004) Nociceptinn inhibits airway microvascular leakage induced by HCl intra-oesophageal instillation. Br J Pharmacol 141:1077–1083PubMedGoogle Scholar
  128. Sant'Ambrogio FB, Sant'Ambrogio G, Anderson JW (1993) Effect of furosemide on the response of laryngeal receptors to low-chloride solutions. Eur Respir J 6:1151–1155PubMedGoogle Scholar
  129. Schroeder K, Fahey T (2004) Over-the-counter medications for acute cough in children and adults in ambulatory settings. Cochrane Database Syst Rev CD001831Google Scholar
  130. Sevelius H, Colmore JP (1966) Objective assessment of antitussive agents in patients with chronic cough. J New Drugs 6:216–233PubMedGoogle Scholar
  131. Sevelius H, McCoy JF, Colmore JP (1971) Dose response to codeine in patients with chronic cough. Clin Pharmacol Ther 12:449–455PubMedGoogle Scholar
  132. Shah S, Page CP, Spina D (1998) Nociceptin inhibits non-adrenergic non-cholinergic contraction in guinea-pig airway. Br J Pharmacol 125:510–516PubMedGoogle Scholar
  133. Shams H, Daffonchio L, Scheid P (1996) Effects of levodropropizine on vagal afferent C-fibres in the cat. Br J Pharmacol 117:853–858PubMedGoogle Scholar
  134. Shoblock JR (2007) The pharmacology of Ro 64–6198, a systemically active, nonpeptide NOP receptor (opiate receptor-like 1, ORL-1) agonist with diverse preclinical therapeutic activity. CNS Drug Rev 13:107–136PubMedGoogle Scholar
  135. Simonyan K, Saad ZS, Loucks TM, Poletto CJ, Ludlow CL (2007) Functional neuroanatomy of human voluntary cough and sniff production. Neuroimage 37:401–409PubMedGoogle Scholar
  136. Smith J, Owen E, Earis J, Woodcock A (2006) Effect of codeine on objective measurement of cough in chronic obstructive pulmonary disease. J Allergy Clin Immunol 117:831–835PubMedGoogle Scholar
  137. Smith MB, Feldman W (1993) Over-the-counter cold medications. A critical review of clinical trials between 1950 and 1991. J Am Med Assoc 269:2258–2263Google Scholar
  138. Stone RA, Worsdell YM, Fuller RW, Barnes PJ (1993) Effects of 5-hydroxytryptamine and 5-hydroxytryptophan infusion on the human cough reflex. J Appl Physiol 74:396–401PubMedGoogle Scholar
  139. Sudo T, Hayashi F, Nishino T (2000) Responses of tracheobronchial receptors to inhaled furosemide in anesthetized rats. Am J Respir Crit Care Med 162:971–975PubMedGoogle Scholar
  140. Szallasi A, Blumberg PM (1999) Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev 51:159–212PubMedGoogle Scholar
  141. Taylor JA, Novack AH, Almquist JR, Rogers JE (1993) Efficacy of cough suppressants in children. J Pediatr 122:799–802PubMedGoogle Scholar
  142. Torrego A, Haque RA, Nguyen LT, Hew M, Carr DH, Wilson R, Chung KF (2006) Capsaicin cough sensitivity in bronchiectasis. Thorax 61:706–709PubMedGoogle Scholar
  143. Trevisani M, Milan A, Gatti R, Zanasi A, Harrison S, Fontana G, Morice AH, Geppetti P (2004) Antitussive activity of iodo-resiniferatoxin in guinea pigs. Thorax 59:769–772PubMedGoogle Scholar
  144. Ueno S, Saitoh A, Kawai K, Natsume K, Sakami S, Maeda M, Ito H, Ohtaki M, Morita K, Kamei J, Endoh T, Nagase H (2001) The rational drug design and antitussive effects of a novel opioid delta receptor antagonist TRK-851. Jpn J Pharmacol 85:S32–S34Google Scholar
  145. Undem BJ, Carr MJ (2001) Pharmacology of airway afferent nerve activity. Respir Res 2:234–244PubMedGoogle Scholar
  146. Usmani OS, Belvisi MG, Patel HJ, Crispino N, Birrell MA, Korbonits M, Korbonits D, Barnes PJ (2005) Theobromine inhibits sensory nerve activation and cough. FASEB J 19:231–233PubMedGoogle Scholar
  147. Vedal S, Petkau J, White R, Blair J (1998) Acute effects of ambient inhalable particles in asthmatic and nonasthmatic children. Am J Respir Crit Care Med 157:1034–1043PubMedGoogle Scholar
  148. Ventresca P, Nichol GM, Barnes PJ, Chung KF (1990) Inhaled furosemide inhibits cough induced by low chloride content solutions and not by capsaicin. Am Rev Respir Dis 142:143–146PubMedGoogle Scholar
  149. von Muhlendahl KE, Scherf-Rahne B, Krienke EG, Baukloh G (1976) Codeine intoxication in childhood. Lancet 2:303–305Google Scholar
  150. Waring JP, Lacayo L, Hunter J, Katz E, Suwak B (1995) Chronic cough and hoarseness in patients with severe gastroesophageal reflux disease. Diagnosis and response to therapy. Dig Dis Sci 40:1093–1097PubMedGoogle Scholar
  151. West S, Brandon B, Stolley P, Rumrill R (1975) A review of antihistamines and the common cold. Pediatrics 56:100–107PubMedGoogle Scholar
  152. Wise SK, Wise JC, DelGaudio JM (2006) Association of nasopharyngeal and laryngopharyngeal reflux with postnasal drip symptomatology in patients with and without rhinosinusitis. Am J Rhinol 20:283–289PubMedGoogle Scholar
  153. Yousaf N, Birring SS (2008) Clinical cough III: measuring cough in the patient. In: Chung KF, Widdicombe JG (eds) Handbook of pharmacology: Pharmacology and therapeutics of cough. Springer, Berlin, this issueGoogle Scholar
  154. Zemp E, Elsasser S, Schindler C, Kunzli N, Perruchoud AP, Domenighetti G, Medici T, Ackermann-Liebrich U, Leuenberger P, Monn C, Bolognini G, Bongard JP, Brandli O, Karrer W, Keller R, Schoni MH, Tschopp JM, Villiger B, Zellweger JP (1999) Long-term ambient air pollution and respiratory symptoms in adults (SAPALDIA study). The SAPALDIA Team. Am J Respir Crit Care Med 159:1257–1266PubMedGoogle Scholar
  155. Zylicz Z, Krajnik M (2004) What has dry cough in common with pruritus? Treatment of dry cough with paroxetine. J Pain Symptom Manage 27:180–184PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2009

Authors and Affiliations

  • K. F. Chung

    There are no affiliations available

    Personalised recommendations